Facilitation of Insulin Effects by Ranolazine in Astrocytes in Primary Culture

Facilitation of Insulin Effects by Ranolazine in Astrocytes in Primary Culture

Ranolazine (Rn) is a drug used to treat persistent chronic coronary ischemia. It has also been shown to have therapeutic benefits on the central nervous system and an anti-diabetic effect by lowering blood glucose levels; however, no effects of Rn on cellular sensitivity to insulin (Ins) have been d...

Full description

Bibliographic Details
Main Authors: Adrián Jordá, Martin Aldasoro, Ignacio Campo-Palacio, Jose M. Vila, Constanza Aldasoro, Juan Campos-Campos, Carlos Colmena, Sandeep Kumar Singh, Elena Obrador, Soraya L. Valles
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:International Journal of Molecular Sciences
Subjects:
ranolazine
insulin
astrocytes
inflammation
antioxidants
Online Access:https://www.mdpi.com/1422-0067/23/19/11969

Internet

https://www.mdpi.com/1422-0067/23/19/11969

Similar Items